English
English Español Português 日本

Articles

Article

3 Optometry Practice Investments = $552K Annually

Review of Optometric Business
October 2024
Investing in technology can significantly enhance patient care while boosting profitability for optometry practices. This article highlights three key technological additions that were made to achieve these outcomes.
Read Now
Article

VEP to the Rescue

Review of Optometry
October 2024
This article discusses where to turn when you are providing treatment in the form of lenses and vision therapy and are not seeing the improvement that you expect.
Read Now
Article

Devices You Might Not Have: Are They a Good Fit?

Review of Optometry
September 2024
This article explores a diverse selection of newer optometric devices, as well as those used in specialized areas of care, designed to help you enhance your skills and advance in specific fields of optometry.
Read Now
Article

3 ROI Winners that Generated $200,000+ Last Year

Review of Optometric Business
June 2024
Dr. Melissa Richard writes about 3 clear winners in her quest to enhance care and spur financial growth, one of them being the RETeval handheld ERG, which she uses to manage her diabetic and low vision patients.
Read Now
Article

8 Reasons to Focus on Diabetes in Your Practice

Review of Optometric Business
May 2024
Dr. Dorothy Hitchmoth explains how the positive impact on public health and the financial rewards make diabetes care a cornerstone for the success and sustainability of optometrists who are willing to embrace this transformative approach.
Read Now
Article

How ERG Helps My Patients and Grows My Practice

Optometry’s Community
April 2024
Read this article to see why Dr. Bobby "Chip" Wood says he thinks the RETeval handheld ERG will change functional testing in 2024 much like OCT revolutionized structural imaging in years past.
Read Now
Article

Recognizing the early signs of diabetic eye disease

Optometric Management
May 2024
With prevalence of diabetes on the rise, recognizing the early signs of diabetic retinopathy is critical for intervention. In this article, Dr. Anna Bedwell discusses devices that can aid in detection and management of the disease.
Read Now
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity